BR0002643A - Compostos bicìclicos de amino-pirazinona, um processo para seu preparo e composições farmacêuticas contendo os mesmos - Google Patents

Compostos bicìclicos de amino-pirazinona, um processo para seu preparo e composições farmacêuticas contendo os mesmos

Info

Publication number
BR0002643A
BR0002643A BR0002643-3A BR0002643A BR0002643A BR 0002643 A BR0002643 A BR 0002643A BR 0002643 A BR0002643 A BR 0002643A BR 0002643 A BR0002643 A BR 0002643A
Authority
BR
Brazil
Prior art keywords
group
preparation
pharmaceutical compositions
compositions containing
same
Prior art date
Application number
BR0002643-3A
Other languages
English (en)
Inventor
Guillaume De Nanteuil
Phillippe Gloanec
Tony Verbeuren
Alain Rupin
Marie-Odile Vallez
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of BR0002643A publication Critical patent/BR0002643A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Patente de Invenção: <B>"COMPOSTOS BICìCLICOS DE AMINO-PIRAZIONA, UM PROCESSO PARA SEU PREPARO E COMPOSIçõES FARMACêUTICAS CONTENDO OS MESMOS"<D>. Composto da fórmula (I): em que: * R~ 1~ representa um átomo de hidrogênio, um grupo alquila, cicloalquila ou heterocicloalquila opcionalmente substituído ou um grupo da fórmula (G): em que A~ 1~ representa uma ligação simples, um grupo -CH~ 2~-, -CH~ 2~-CH~ 2~- ou -N(CH~ 3~)- ou um átomo de enxofre ou oxigênio e X1 e X2, os quais podem ser idênticos ou diferentes representam, cada um, um átomo de carbono ou nitrogênio, - R representa um átomo de hidrogênio ou um grupo (C~ 1~-C~ 6~) alquila linear ou ramificada, - <sym> representa um anel saturado tendo de 4 a 7 elementos no anel, - n representa um número inteiro em que 1 <243> n <243> 6, - Ar representa um grupo arila ou heteroarila, seus isómeros, seus N-óxidos e sais de adição dos mesmos com um ácido ou base farmaceuticamente aceitável. Medicamentos.
BR0002643-3A 1999-06-15 2000-06-15 Compostos bicìclicos de amino-pirazinona, um processo para seu preparo e composições farmacêuticas contendo os mesmos BR0002643A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9907538A FR2795072B1 (fr) 1999-06-15 1999-06-15 Nouveaux derives bicycliques d'amino-pyrazinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
BR0002643A true BR0002643A (pt) 2001-01-02

Family

ID=9546789

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0002643-3A BR0002643A (pt) 1999-06-15 2000-06-15 Compostos bicìclicos de amino-pirazinona, um processo para seu preparo e composições farmacêuticas contendo os mesmos

Country Status (23)

Country Link
US (1) US6277851B1 (pt)
EP (1) EP1069132B1 (pt)
JP (1) JP3364472B2 (pt)
KR (1) KR100456796B1 (pt)
CN (1) CN1147489C (pt)
AT (1) ATE251177T1 (pt)
AU (1) AU766194B2 (pt)
BR (1) BR0002643A (pt)
CA (1) CA2312206C (pt)
DE (1) DE60005609T2 (pt)
DK (1) DK1069132T3 (pt)
EA (1) EA003209B1 (pt)
ES (1) ES2208239T3 (pt)
FR (1) FR2795072B1 (pt)
HK (1) HK1032236A1 (pt)
HU (1) HUP0002277A3 (pt)
NO (1) NO316650B1 (pt)
NZ (1) NZ505149A (pt)
PL (1) PL199522B1 (pt)
PT (1) PT1069132E (pt)
SE (1) SE1069132T5 (pt)
SI (1) SI1069132T1 (pt)
ZA (1) ZA200003034B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064678A2 (en) * 2000-02-29 2001-09-07 Bristol-Myers Squibb Pharma Company Inhibitors of hepatitis c virus ns3 protease
FR2818277B1 (fr) * 2000-12-14 2003-01-24 Servier Lab Nouveaux derives bicycliques d'amino-pyrazinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2004002405A2 (en) * 2002-06-26 2004-01-08 Bristol-Myers Squibb Company Amino-bicyclic pyrazinones and pyridinones
FR2867780B1 (fr) * 2004-03-19 2006-05-19 Servier Lab Nouveaux derives de 4-oxo-4,6,7,8-tetrahydropyrrolo (1,2-a) pyrazine-6-carboxamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP2807156A1 (en) * 2012-01-27 2014-12-03 Novartis AG Aminopyridine derivatives as plasma kallikrein inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05117276A (ja) * 1991-10-23 1993-05-14 Sumitomo Pharmaceut Co Ltd 新規な3環性キノキサリンジオン誘導体
EE9700113A (et) * 1994-12-22 1997-12-15 Biochem Pharma Inc. Madala molekulmassiga bitsüklilised trombiini inhibiitorid
WO1996030396A1 (en) * 1995-03-24 1996-10-03 Molecumetics Ltd. β-SHEET MIMETICS AND USE THEREOF AS PROTEASE INHIBITORS
CA2245811A1 (en) * 1996-02-22 1997-08-28 Merck & Co., Inc. Pyridinone thrombin inhibitors
WO1997048706A1 (en) * 1996-06-18 1997-12-24 Warner-Lambert Company Pyrrolo[1,2-a]pyrazine-1,4-dione serine protease inhibitors
AU4172397A (en) * 1996-09-06 1998-03-26 Biochem Pharma Inc. Lactam inhibitors of thrombin
ATE234091T1 (de) * 1996-10-24 2003-03-15 Merck & Co Inc Thrombin inhibitoren
US5792779A (en) * 1997-02-19 1998-08-11 Merck & Co., Inc. Pyridinone thrombin inhibitors
AU740447B2 (en) * 1997-09-23 2001-11-01 Merck & Co., Inc. Thrombin inhibitors

Also Published As

Publication number Publication date
HU0002277D0 (en) 2000-08-28
NZ505149A (en) 2001-01-26
FR2795072A1 (fr) 2000-12-22
JP2001026592A (ja) 2001-01-30
EA200000527A2 (ru) 2000-12-25
EP1069132B1 (fr) 2003-10-01
JP3364472B2 (ja) 2003-01-08
FR2795072B1 (fr) 2001-07-27
HUP0002277A2 (hu) 2001-05-28
EP1069132A1 (fr) 2001-01-17
AU4086500A (en) 2000-12-21
CA2312206C (fr) 2004-07-06
HUP0002277A3 (en) 2002-12-28
KR100456796B1 (ko) 2004-11-10
DE60005609T2 (de) 2004-08-05
CA2312206A1 (fr) 2000-12-15
ES2208239T3 (es) 2004-06-16
PL340784A1 (en) 2000-12-18
CN1147489C (zh) 2004-04-28
EA003209B1 (ru) 2003-02-27
PT1069132E (pt) 2004-02-27
NO20002941D0 (no) 2000-06-08
PL199522B1 (pl) 2008-09-30
SI1069132T1 (en) 2003-12-31
DE60005609D1 (de) 2003-11-06
DK1069132T3 (da) 2004-02-02
CN1277198A (zh) 2000-12-20
US6277851B1 (en) 2001-08-21
SE1069132T3 (sv) 2003-12-09
ATE251177T1 (de) 2003-10-15
NO20002941L (no) 2000-12-18
ZA200003034B (en) 2001-01-11
EA200000527A3 (ru) 2001-04-23
KR20010066846A (ko) 2001-07-11
HK1032236A1 (en) 2001-07-13
AU766194B2 (en) 2003-10-09
NO316650B1 (no) 2004-03-22
SE1069132T5 (sv) 2004-01-07

Similar Documents

Publication Publication Date Title
BR0003848A (pt) Compostos de piridina, processo para sua preparação e composições farmacêuticas que os contêm
BR0003105A (pt) Compostos de beta-carbolina, processo para sua preparação e composições farmacêuticas contendo os mesmos
PT1285651E (pt) Antagonistas da hormona concentradora da melanina
BR0200982A (pt) Compostos do ácido alfa-amino sulfonila, um processo para sua preparação e composições farmacêuticas compreendendo os mesmos
BR0014641A (pt) Derivados de sulfonamida farmaceuticamente ativa, uso de um derivado de sulfonamida, uso de sulfonamidas, composto farmacêutico contendo pelo menos um derivado de sulfonamida e processo para preparação de um derivado de sulfonamida
BR0104471A (pt) Compostos de ciclobutenodiona, um processo para a preparação dos mesmos e composições farmacêuticas que contêm os mesmos
BR0002643A (pt) Compostos bicìclicos de amino-pirazinona, um processo para seu preparo e composições farmacêuticas contendo os mesmos
BR0005557A (pt) Compostos diidrofuro[3,4-b] quinolin-1-ona, processo para a preparação dos mesmos e composições farmacêuticas contendo os mesmos
BR0100107A (pt) Compostos de benzenossulfonamida, um processo para sua preparação e composições farmacêuticas que contêm os mesmos
BR0312107A (pt) Derivados de tiazina e de oxazina como inibidores de mmp-13 para o tratamento da artrite
BR0202681A (pt) Compostos de octaidro-2h-pirido[1,2a]pirazina, um processo para sua preparação e composições farmacêuticas contendo-as
ES543787A0 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo piridinometoxi sustituido y de sus sales deadicion acidas y cuaternarias
DK0937043T3 (da) Substituerede tetrahydropyridin-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse derivater
BR0106248A (pt) Inibidores de metaloprotease, processo para a sua preparação e composições farmacêuticas contendo os mesmos
BR0106129A (pt) Compostos de amino-pirazinona bicìclicos, processo para sua preparação e composições farmacêuticas contendo-os
BR0007348A (pt) Uréias cìclicas ou lineares, processo para seupreparo e composições farmacêuticas contendo asmesmas
BR0103070A (pt) Compostos benzotiadiazina, processo para sua preparação e composições farmacêuticas contendo os mesmos
EA200400756A1 (ru) Новые соединения бензотиазина и бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат
ES543792A0 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo piperidinopropanolico sustituido y de sus sales de adicion acidas y amonicas cuaternarias
BR0101444A (pt) Compostos de heterocicloalquilbenzociclobutanoe de heteroarilbenzociclobutano, processo parasua preparação e composições farmacêuticascontendo os mesmos
BR0002076A (pt) Compostos 1-aza-2-alquil-6-aril-cicloalcano, um processo para sua preparação e composições farmacêuticas contendo estes
BR0101466A (pt) Compostos de ciclobutaindolcarboxamida,processo para a sua preparação e composiçõesfarmacêuticas contendo os mesmos
BR0202313A (pt) Compostos cìclicos de alfa-amino-gama-hidroxiamida, um processo para a preparação dos mesmos e composições farmacêuticas que contem os mesmos
ATE26271T1 (de) Benzhydrylpiperazine-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
NO178137C (no) Fremgangsmåte for fremstilling av et polyprenylholdig farmasöytisk preparat i form av harde kapsler

Legal Events

Date Code Title Description
PC Transfer

Free format text: LES LABORATOIRES SERVIER (FR)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: A61K 9/70, C07D 471/04, C07D 487/04, C07D 498/04, C07D 513/04, A61K 31/4985, A61P 7/02

Ipc: A61K 31/397 (2009.01), A61K 31/4985 (2009.01), A61

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time